Presentation is loading. Please wait.

Presentation is loading. Please wait.

Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?  Andreas Charidimou, Hans Rolf J Jäger  The.

Similar presentations


Presentation on theme: "Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?  Andreas Charidimou, Hans Rolf J Jäger  The."— Presentation transcript:

1 Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?  Andreas Charidimou, Hans Rolf J Jäger  The Lancet Neurology  Volume 13, Issue 6, Pages (June 2014) DOI: /S (14) Copyright © 2014 Elsevier Ltd Terms and Conditions

2 A T2*-weighted MRI in a 69-year-old man with probable cerebral amyloid angiopathy
The Lancet Neurology  , DOI: ( /S (14) ) Copyright © 2014 Elsevier Ltd Terms and Conditions


Download ppt "Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?  Andreas Charidimou, Hans Rolf J Jäger  The."

Similar presentations


Ads by Google